focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.025
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.05 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.025
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

4 Feb 2021 10:22

RNS Number : 0131O
Microsaic Systems plc
04 February 2021
 

4 February 2021

Microsaic Systems plc

("Microsaic" or the "Company")

Result of General Meeting and Total Voting Rights

Microsaic Systems plc (AIM: MSYS), the point-of-need mass spectrometry company, is pleased to announce that, at its General Meeting held earlier today in connection with the fundraise, the share reorganisation and the proposed Board changes announced on 19 January 2021, all Resolutions were put to a meeting on a poll and were duly passed. The voting results from the General Meeting are included at the foot of this announcement.

Application has been made to the London Stock Exchange for 5,620,000,000 new ordinary shares of 0.01 pence each ("Ordinary Shares"), which comprise the Placing Shares, the Fees Shares and the Broker Option Shares, to be admitted to trading on AIM. It is expected that Admission will occur and dealings will commence on 5 February 2021 at 8.00 a.m.

Total voting rights

Following Admission, the Company will have 6,076,365,146 Ordinary Shares in issue. The Company holds no shares in treasury. Therefore, the Company hereby confirms that the total number of voting rights in the Company will, following Admission, be 6,076,365,146.

Shareholders may use this figure of 6,076,365,146 as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Rules and Transparency Rules.

A separate announcement will be made tomorrow relating to the planned Board changes which will become effective immediately following Admission.

 

Defined terms used in this announcement have the meanings (unless the context otherwise requires) set out in the Circular dated 19 January 2021, which is available on the Company's website at https://www.microsaic.com/investors/documents/.

 

Glenn Tracey, CEO of Microsaic, commented:

''We are delighted to have received substantial support from our existing shareholders, and welcome the significant support from new shareholders introduced by Turner Pope. The net proceeds from the Placing are expected to accelerate commercialisation of Microsaic's miniaturised products and services by expanding sales, marketing and distribution channels through collaboration, cooperation and partnerships. Beyond general working capital use, funding will be directed to targeting new revenue streams by exploring out-licensing opportunities of our robust IP portfolio while sharing costs of joint development that may lead to new income from shared products and services."

 

 

Enquiries:

 

 

Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD

+44 (0)1483 751 577

 

N+1 Singer (Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / George Tzimas (Corporate Finance)

 

Tom Salvesen (Corporate Broking)

 

 

Turner Pope Investments (TPI) Limited (Joint Broker)

Zoe Alexander (Corporate Broking)

Andy Thacker (Corporate Broking)

 +44 (0)20 3657 0050

 

 

General Meeting voting results:

 

Resolutions

Votes 

For

% of votes cast

Votes

Against

% of votes cast

Votes

Withheld

1*

To approve the proposed amendments to the Company's existing articles of association, as set out in the Notice of General Meeting.

330,985,981

99.94

210,338

0.06

11,742,973

2

To approve the share reorganisation as set out in the Notice of General Meeting.

340,785,981

99.94

210,338

0.06

1,942,973

3

To grant the Directors authority to allot equity securities in the Company in the amounts set out in the Notice of General Meeting.

340,772,440

99.93

223,879

0.07

1,942,973

4*

To empower the Directors to disapply pre-emption rights on the issue of equity securities in the Company in the amounts set out in the Notice of General Meeting.

340,780,981

99.94

215,338

0.06

1,942,973

5

To appoint Gerard Brandon as a Director of the Company.

342,585,981

99.94

210,338

0.06

142,973

6

To appoint Nigel Burton as a Director of the Company.

342,585,981

99.94

210,338

0.06

142,973

*Special Resolution

 

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company which develops point-of-need mass spectrometers (MS) designed to improve the efficiency of chemical and biological workflows.

The Company was initially established to develop miniaturised MS instruments based on micro-electromechanical systems (MEMS) technology originating at the highly regarded Optical and Semiconductor Devices Group at Imperial College London. Since being established in 2001, the Company has invested substantially in core intellectual property specific to its miniaturised MS, with over 60 patents in chip based, compact MS.

 

The Company has sold over 160 instruments to date and has signed over ten commercial partners, including in North America, Europe, China, SE Asia and Japan, with the majority of signings occurring in 2018 and 2019. For more information, please go to www.microsaic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMDKQBBKBKDKBK
Date   Source Headline
14th Sep 20163:38 pmRNSGrant of Options
13th Sep 20164:46 pmRNSHolding(s) in Company
13th Sep 201610:45 amRNSHolding(s) in Company
13th Sep 20168:40 amRNSHolding(s) in Company
13th Sep 20168:30 amRNSDirector/PDMR Shareholding
12th Sep 201611:53 amRNSResult of GM, Completion of Placing, TVRs
26th Aug 20164:49 pmRNSResult of Placing
26th Aug 20161:15 pmRNSProposed Placing of New Shares
26th Aug 20161:15 pmRNSHalf-year Report
20th Jun 20163:27 pmRNSAGM Statement
13th Jun 20167:00 amRNSChange of Nominated Adviser and Broker
19th May 20167:00 amRNSDistribution of Annual Report and Accounts
13th May 201612:57 pmRNSAGM Change of Date
16th Mar 20167:00 amRNSAnnual Financial Report
8th Mar 20167:00 amRNSDirectorate Change
24th Feb 20167:00 amRNSTrading Statement
14th Jan 20167:00 amRNSAward of Options
21st Dec 20157:00 amRNSDirectorate Change
2nd Dec 20157:04 amRNSTrading Update & Directorate Change
30th Nov 201511:47 amRNSHolding(s) in Company
23rd Oct 201511:41 amRNSHolding(s) in Company
22nd Oct 20151:12 pmRNSHolding(s) in Company
19th Oct 20151:37 pmRNSResults of EGM and Placing
15th Oct 20157:00 amRNSPlacing - Exercise of Additional Demand Option
13th Oct 20153:30 pmRNSDirector/PDMR Shareholding
30th Sep 20157:44 amRNSPlacing of New Shares
30th Sep 20157:00 amRNSInterim Results
20th May 20157:00 amRNSResult of AGM
8th Apr 20158:34 amRNSNotification of Major Interest in Shares
30th Mar 20157:00 amRNSDistribution of Annual Report and Accounts
23rd Mar 20157:00 amRNSAnnual Financial Report
19th Mar 20157:00 amRNSAppoinment of Chief Operating Officer
16th Mar 20157:00 amRNSOEM Supply Agreement with GE Healthcare
6th Jan 20158:40 amRNSExercise of Share Options
28th Oct 20149:16 amRNSHolding(s) in Company
14th Oct 20142:10 pmRNSHolding(s) in Company
10th Oct 20144:19 pmRNSHolding(s) in Company
10th Oct 20141:15 pmRNSExercise of Share Options
8th Oct 20147:00 amRNSDirectors' Dealings
7th Oct 20147:00 amRNSConditional Placing to Raise £4.4 million
30th Sep 20147:00 amRNSInterim Results
29th Sep 201412:23 pmRNSCommercial Agreement with Gilson Inc.
25th Sep 20147:00 amRNSMicrosaic Systems Signs Commercial Agreement
9th Sep 20147:00 amRNSPlexus chosen as commercial manufacturing partner
15th Jul 201410:06 amRNSDirectorate Change
23rd Jun 20143:08 pmRNSHolding(s) in Company
19th Jun 201412:02 pmRNSHolding(s) in Company
13th Jun 20149:00 amRNSDISTRIBUTION OF ANNUAL REPORT & ACCOUNTS
10th Jun 20149:10 amRNSExercise of share options
3rd Jun 20147:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.